Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Accounts Payables (2018 - 2025)

TELA Bio has reported Accounts Payables over the past 8 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Accounts Payables at $2.3 million for Q4 2025, up 7.55% from a year ago — trailing twelve months through Dec 2025 was $2.3 million (up 7.55% YoY), and the annual figure for FY2025 was $2.3 million, up 7.55%.
  • Accounts Payables for Q4 2025 was $2.3 million at TELA Bio, down from $2.4 million in the prior quarter.
  • Over the last five years, Accounts Payables for TELA hit a ceiling of $5.7 million in Q1 2022 and a floor of $965000.0 in Q1 2021.
  • Median Accounts Payables over the past 5 years was $2.3 million (2021), compared with a mean of $2.7 million.
  • Peak annual rise in Accounts Payables hit 490.98% in 2022, while the deepest fall reached 36.45% in 2022.
  • TELA Bio's Accounts Payables stood at $2.4 million in 2021, then plummeted by 36.45% to $1.5 million in 2022, then rose by 8.67% to $1.7 million in 2023, then grew by 28.79% to $2.1 million in 2024, then rose by 7.55% to $2.3 million in 2025.
  • The last three reported values for Accounts Payables were $2.3 million (Q4 2025), $2.4 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.